Pharmaceuticals

Drug Formulation Market Trends and Insights: Global Forecast to 2030

February 13, 2026February 13, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the drug formulation market from 2026–2035 with trusted insights from The Business Research Company

How is the Drug Formulation Market size predicted to change over the forecast window of 2026–2035?

The drug formulation market has demonstrated substantial growth in recent years. Its size is anticipated to expand from $2045.31 billion in 2025 to $2221.54 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. This historical development can be ascribed to an increase in generic drug demand, the rising occurrence of chronic diseases, progress in pharmaceutical research, the enlargement of hospital and clinic networks, and heightened investments in research and development.

The drug formulation market size is projected to experience robust expansion in the coming years. By 2030, this market is anticipated to reach $3196.24 billion, demonstrating a compound annual growth rate (CAGR) of 9.5%. Several factors are contributing to this growth over the forecast period, including the emergence of gene and cell therapies, the adoption of AI in drug design, the development of novel excipients, a rise in biologics and specialty drugs, and the expansion of emerging pharmaceutical markets. Key trends expected during the forecast period encompass personalized drug formulations, advanced drug delivery systems, the development of biologics and biosimilars, efforts in formulation stability and shelf-life optimization, and a focus on regulatory compliance and quality assurance.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9900&type=smp

Which Drivers Are Contributing To The Expansion Of The Drug Formulation Market?

The rising uptake of personalized medicine is anticipated to boost the drug formulation market’s expansion. This innovative healthcare method customizes medical treatments and interventions for each patient’s unique attributes, specifically by adapting therapies based on individual patient traits like genetics and biomarkers. This approach necessitates creating custom drug formulations to maximize effectiveness and safety for every patient. The implications include a demand for individual treatment plans, formulations that incorporate genomic insights, improved drug responses, and specialized therapies for uncommon conditions. For example, in 2023, according to the Personalized Medicine Coalition (PMC), a US-based non-profit, personalized medicines constituted approximately 38 percent of all newly approved therapeutic molecular entities, an increase from 34 percent in 2022. Consequently, the growing acceptance of personalized medicine is fueling the growth of the drug formulation market.

What Segment Categories Are Covered In The Drug Formulation Market?

The drug formulation market covered in this report is segmented –

1) By Dosage Form: Oral formulations, Parenteral Formulations, Topical Formulations, Inhalation Formulations

2) By Formulation: Tablets, Capsules, Injectable, Sprays, Suspensions, Powders, Other Formulations

3) By Therapy Area: Cardiovascular Diseases (CVDs), Pain, Diabetes, Cancer, Respiratory Diseases, Other Diseases

4) By End-User: Big Pharma, Small And Medium Pharma, Biotech Companies

Subsegments:

1) By Oral Formulations: Tablets, Capsules, Powders, Liquids Or Solutions

2) By Parenteral Formulations: Injectables, Implants, Infusions

3) By Topical Formulations: Creams, Ointments, Gels, Transdermal Patches

4) By Inhalation Formulations: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

What Industry Trends Are Transforming The Drug Formulation Market?

Major pharmaceutical companies operating in the drug formulation market are developing new fixed dose combination drugs for type 2 diabetes to gain a competitive edge. A Fixed Dose Combination (FDC) refers to a pharmaceutical formulation containing two or more active ingredients combined in a fixed ratio of doses within a single dosage form. For instance, in October 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched its first triple-drug fixed-dose combination under the brand name Zita DM. This medication contains the DPP4 inhibitor, Teneligliptin (20mg), the SGLT2 inhibitor, Dapagliflozin, (10mg), and Metformin SR (500mg/1000mg) in a fixed dose. It is intended to be taken once daily, under prescription, to improve glycemic control in patients with Type 2 diabetes.

Which Major Firms Are Strengthening Their Position In The Drug Formulation Market?

Major companies operating in the drug formulation market are AstraZeneca PLC, The Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Pfizer Inc., AbbVie Inc., C.H. Boehringer Sohn AG & Co. KG, F. Hoffmann-La Roche AG, Johnson & Johnson, Bayer AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., GlaxoSmithKline plc, Novo Nordisk A/S, Amgen Inc., Viatris Inc., Sandoz International GmbH, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Lupin Limited, Torrent Pharmaceuticals Limited, Jubilant Life Sciences Limited, Cadila Healthcare Limited, Glenmark Pharmaceuticals Ltd., Wockhardt Ltd., Hikma Pharmaceuticals plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Drug Formulation Market?

North America was the largest region in the drug formulation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the drug formulation market report during the forecast period. The regions covered in the drug formulation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Formulation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9900&type=smp

Browse Through More Reports Similar to the Global Drug Formulation Market 2026, By The Business Research Company

Drug Formulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-formulation-global-market-report

Oral Solid Dosage Pharmaceutical Formulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-pharmaceutical-formulation-global-market-report

Active Pharmaceutical Ingredients Market Report 2026

https://www.thebusinessresearchcompany.com/report/active-pharmaceutical-ingredients-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795